Total Liabilities Equity - AC Immune SA (NASDAQ:ACIU) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 4.62 USD -4.35%

Updated:

AC Immune SA
Total Liabilities & Equity

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

AC Immune SA
Total Liabilities & Equity Peer Comparison

ADCT

CRSP

BSLN

IDIA

KURN

Company		Total Liabilities & Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
	AC Immune SA NASDAQ:ACIU	Total Liabilities & Equity CHf167.3m	CAGR 3-Years -10%	CAGR 5-Years -12%	CAGR 10-Years N/A
	ADC Therapeutics SA NYSE:ADCT	Total Liabilities & Equity $354.8m	CAGR 3-Years -12%	CAGR 5-Years 19%	CAGR 10-Years N/A
	CRISPR Therapeutics AG NASDAQ:CRSP	Total Liabilities & Equity $2.4B	CAGR 3-Years 8%	CAGR 5-Years 37%	CAGR 10-Years N/A
	Basilea Pharmaceutica AG SIX:BSLN	Total Liabilities & Equity CHf173.3m	CAGR 3-Years -9%	CAGR 5-Years -9%	CAGR 10-Years -5%
	Idorsia Ltd SIX:IDIA	Total Liabilities & Equity CHf500m	CAGR 3-Years -30%	CAGR 5-Years -19%	CAGR 10-Years N/A
	Kuros Biosciences AG SIX:KURN	Total Liabilities & Equity CHf71.5m	CAGR 3-Years -9%	CAGR 5-Years -4%	CAGR 10-Years N/A

See Also

Based on the financial report for Mar 31, 2024, AC Immune SA's Total Liabilities & Equity amounts to 167.3m CHF.

Over the last year, the Total Liabilities & Equity growth was -1%. The average annual Total Liabilities & Equity growth rates for AC Immune SA have been -10% over the past three years , -12% over the past five years .

Join more than 144,100+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.